PET imaging of beta-amyloid levels using Pittsburgh compound B or florbetapir yielded consistent results, according to a study in the Journal of Nuclear Medicine. The two methods gave concordant beta-amyloid positive and negative status and comparable cortical retention ratios, the study found. "These analyses are an initial step in addressing the need for standardization of AB methodologies," researchers said.

Full Story:

Related Summaries